NDSI
RXII

Newman Dignan & Sheerar Inc’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Newman Dignan & Sheerar Inc’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-12,550
Closed -$62K – 150
2013
Q4 		$62K Buy
+12,550
New +$62K 0.04% 149

Other funds holding RXII

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Newman Dignan & Sheerar Inc's RXII Position: Q1 2014 in Review

Newman Dignan & Sheerar Inc sold out of GALENA BIOPHARMA INC COM (RXII) in Q1 2014, closing a stake of 12,550 shares — an estimated $62K sold.

Newman Dignan & Sheerar Inc first reported a position in RXII in Q4 2013 and held it in 1 quarter. The position peaked at $62K in Q4 2013. 88 funds tracked by Wall St. Rank hold RXII as of Q1 2014.

  • Newman Dignan & Sheerar Inc reported no remaining GALENA BIOPHARMA INC COM position as of Q1 2014 after selling out during the quarter.
  • Newman Dignan & Sheerar Inc sold 12,550 GALENA BIOPHARMA INC COM shares in Q1 2014, an estimated $62K.
  • Newman Dignan & Sheerar Inc first reported a position in GALENA BIOPHARMA INC COM in Q4 2013 and held it in 1 quarter.
  • Newman Dignan & Sheerar Inc's GALENA BIOPHARMA INC COM position peaked at $62K in Q4 2013.
  • 88 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q1 2014.

Based on Newman Dignan & Sheerar Inc's 13F filing for Q1 2014, filed 7 May 2014.